DEFA14A: Universal Safety Products Approves Key Plans, Adjourns Vote

Universal Safety Products, Inc. stockholders approved its 2025 Equity Incentive Plan, equity issuances to directors and officers, and a convertible note issuance, but adjourned votes on share structure changes to solicit more proxies.

Summary

• A special meeting of stockholders was held on October 20, 2025.
• As of the September 17, 2025 record date, 2,312,887 shares of common stock were outstanding and entitled to vote.
• Stockholders approved the 2025 Equity Incentive Plan with 931,883 votes For, 58,273 Against, 2,839 Abstain, and 504,550 Broker Non-Votes.
• Stockholders approved equity issuances to directors and executive officers with 861,029 votes For, 107,310 Against, 24,656 Abstain, and 504,550 Broker Non-Votes.
• Stockholders approved the issuance of additional common stock underlying a convertible note from August 13, 2025, to comply with NYSE American Rule 713(a), with 953,153 votes For, 32,616 Against, 7,226 Abstain, and 504,550 Broker Non-Votes.
• Stockholders approved the adjournment of the Special Meeting if necessary to solicit further proxies with 1,294,006 votes For, 194,077 Against, 9,462 Abstain, and 0 Broker Non-Votes.
• The meeting was adjourned without opening polls on the Authorized Share Increase Proposal, Blank Check Preferred Proposal, Class B Common Proposal, and Voting Rights Proposal due to insufficient votes.
• The Adjourned Special Meeting will reconvene on Friday, November 14, 2025, at 12:00 p.m. Eastern Time.
• The company will continue to accept stockholder votes on the adjourned proposals during the period of adjournment.

Sentiment

Score: 6

Explanation: While key operational proposals passed, the need to adjourn significant corporate structure changes due to insufficient votes indicates some shareholder resistance or apathy, which is a slight negative. However, the company has a clear plan to address this.

Positives

• Approval of the 2025 Equity Incentive Plan, which is crucial for employee and executive motivation and retention.
• Approval of equity issuances to directors and executive officers, aligning management interests with shareholder value.
• Approval of the common stock issuance related to the convertible note, ensuring compliance with NYSE American rules.
• Approval of the adjournment mechanism, providing a strategic pathway to secure necessary votes for critical proposals.

Negatives

• Insufficient votes to approve significant corporate structure changes, including the Authorized Share Increase Proposal, Blank Check Preferred Proposal, Class B Common Proposal, and Voting Rights Proposal, necessitating an adjournment.
• The need for an adjournment indicates a lack of initial shareholder consensus or engagement on fundamental governance and capital structure matters.

Risks

• Actual results may differ materially from forward-looking statements due to inherent uncertainties and risks.
• Risk of not securing sufficient votes for critical corporate structure proposals (Authorized Share Increase, Blank Check Preferred, Class B Common, Voting Rights) even after the reconvened meeting.

Future Outlook

The company will continue to accept stockholder votes on the Authorized Share Increase Proposal, the Blank Check Preferred Proposal, the Class B Common Proposal and the Voting Rights Proposal during the period of adjournment, with the Adjourned Special Meeting reconvening on November 14, 2025.

Management Comments

• Investors are cautioned not to rely unduly on forward-looking statements when evaluating the information presented within.
• The Company strongly encourages all of its shareholders to read the Proxy Statement (including any amendments or supplements thereto) and other proxy materials relating to the Special Meeting.

Industry Context

na

Corporate Governance

Stakeholder Impact

• Shareholders: Directly impacted by voting outcomes, potential dilution from approved equity issuances and convertible note conversion, and delayed decisions on significant capital structure changes.
• Employees & Executives: Positively impacted by the approval of the 2025 Equity Incentive Plan and equity issuances, providing incentives and retention tools.
• Creditors (Convertible Note Holders): The approval of common stock issuance for the convertible note facilitates the conversion process, impacting their investment.

Next Steps

• The Adjourned Special Meeting will reconvene on November 14, 2025, at 12:00 p.m. Eastern Time.
• The company will continue to accept stockholder votes on the Authorized Share Increase Proposal, the Blank Check Preferred Proposal, the Class B Common Proposal, and the Voting Rights Proposal.
• Stockholders who have previously voted and do not wish to change their vote do not need to take any action.

Key Dates

Recommendation

The company successfully passed several key proposals related to executive compensation and regulatory compliance. However, the adjournment of significant capital structure changes (Authorized Share Increase, Blank Check Preferred, Class B Common, and Voting Rights) due to insufficient votes introduces uncertainty. While the company is actively soliciting further proxies, the delay and initial lack of shareholder consensus on these fundamental changes warrant a 'hold' recommendation until the outcome of the reconvened meeting is clear and the implications of these proposals are fully understood.

Keywords

Universal Safety Products, Special Meeting, Stockholder Vote, Equity Incentive Plan, Convertible Note, Proxy Solicitation, Corporate Governance, Shareholder Meeting, NYSE American, Adjournment